Serum inflammatory mediators as markers of human Lyme disease activity.
about
Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease.Development of a metabolic biosignature for detection of early Lyme disease.Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme DiseaseCCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort StudyThe Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease.Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohortVariable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding.Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling.IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis.Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report.A multi-omic analysis reveals the regulatory role of CD180 during the response of macrophages to Borrelia burgdorferi.
P2860
Q36297670-2A9A6B24-08FC-406B-8C5C-FE17491C4022Q36687055-26BAB0C3-345E-4B8A-946A-FB6F12AAD415Q36737157-F5E6FF45-4860-4168-9F04-41FEF3396959Q36764399-20827F07-595D-43AF-9800-3E43F96E7DDAQ37239565-2670C573-22DD-454C-BF76-2CD6B5C698A0Q37679914-B77A5AD1-CA98-4C38-8127-63C5913811C7Q39431370-44C1D7A9-5B10-4AC0-BD6E-C70FA320B37AQ41503473-6DC10587-1C98-495D-8EFC-BF8A4A3846FBQ41558997-3FCE99E8-DBFF-420E-B6C6-2622E8E46100Q46181782-5CBF44E7-9F5B-4090-9E7C-0AC438D50E6EQ47620767-72F37F83-AE0D-4FEF-86AE-83253D63A357Q48251828-69F6FB2C-D7BA-42B9-8AA3-9BA3A9B473FEQ55100972-99FF688D-6D42-4F39-823D-15D2964BDC92Q55133030-D8DA2A8D-8103-4D71-9B45-914046AF3289
P2860
Serum inflammatory mediators as markers of human Lyme disease activity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serum inflammatory mediators as markers of human Lyme disease activity.
@ast
Serum inflammatory mediators as markers of human Lyme disease activity.
@en
type
label
Serum inflammatory mediators as markers of human Lyme disease activity.
@ast
Serum inflammatory mediators as markers of human Lyme disease activity.
@en
prefLabel
Serum inflammatory mediators as markers of human Lyme disease activity.
@ast
Serum inflammatory mediators as markers of human Lyme disease activity.
@en
P2093
P2860
P1433
P1476
Serum inflammatory mediators as markers of human Lyme disease activity.
@en
P2093
Catriona A Wagner
John N Aucott
Lauren A Crowder
Lauren J Lahey
Mark J Soloski
William H Robinson
P2860
P304
P356
10.1371/JOURNAL.PONE.0093243
P407
P577
2014-04-16T00:00:00Z